We are live on ! Find out more
ADMA icon

ADMA Biologics
ADMA

365 hedge funds and large institutions have $3.28B invested in ADMA Biologics in 2025 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 98 increasing their positions, 160 reducing their positions, and 64 closing their positions.

New
Increased
Maintained
Reduced
Closed

110% more call options, than puts

Call options by funds: $69.2M | Put options by funds: $32.9M

3.52% more ownership

Funds ownership: 88.39% → 91.91% (+3.5%)

2% more first-time investments, than exits

New positions opened: 65 | Existing positions closed: 64

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

1% less funds holding

Funds holding: 368 → 365 (-3)

15% less capital invested

Capital invested by funds: $3.84B → $3.28B (-$562M)

39% less repeat investments, than reductions

Existing positions increased: 98 | Existing positions reduced: 160

Holders
365
Holders Change
-3
Holders Change %
-0.82%
% of All Funds
4.79%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
65
Increased
98
Reduced
160
Closed
64
Calls
$69.2M
Puts
$32.9M
Net Calls
+$36.2M
Net Calls Change
+$14.5M

Top Buyers

1
SHCM
Sachem Head Capital Management
New York
+$154M
2
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$87.5M
3
Capital Research Global Investors
Capital Research Global Investors
California
+$55.8M
4
CP
Caligan Partners
New York
+$45.2M
5
Citadel Advisors
Citadel Advisors
Florida
+$36.3M

Top Sellers

1
DCM
Driehaus Capital Management
Illinois
-$45.1M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$42.5M
3
VNIM
Vaughan Nelson Investment Management
Texas
-$32.8M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$32.4M
5
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$30.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
CT
426
Colonial Trust
South Carolina
– -$4.54K -250 Closed
AGWCA
427
Annis Gardner Whiting Capital Advisors
Florida
– -$1.64K -90 Closed
PWA
428
Physician Wealth Advisors
Utah
– -$456 -25 Closed
CCM
429
Cloud Capital Management
Washington
– +$120 +7 New
14 15 16 17
18

ADMA Hedge Fund Activity: Q3 2025 in Review

365 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in ADMA Biologics (ADMA) for Q3 2025, worth a combined $3.28B — down 15% from $3.84B a quarter earlier.

Buyers outnumbered sellers: 65 funds opened new ADMA positions and 64 closed out — a net gain of 1 holder — while 98 added to existing stakes and 160 trimmed.

The largest buyer was Sachem Head Capital Management, opening a new position worth an estimated $154M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $45.1M sold.

  • 365 institutional investors held ADMA Biologics (ADMA) as of Q3 2025, down from 368 in Q2 2025.
  • Funds reported $3.28B of ADMA Biologics stock for Q3 2025, down 15% quarter-over-quarter.
  • 65 funds opened new ADMA Biologics positions in Q3 2025 and 64 closed out, a net change of +1 holder.
  • The largest ADMA Biologics buyer in Q3 2025 was Sachem Head Capital Management, an estimated $154M added.
  • The largest ADMA Biologics seller in Q3 2025 was Driehaus Capital Management, an estimated $45.1M sold.

Based on aggregated 13F filings for Q3 2025.